Skip to main content
$0.94 $0.00 (-0.2%)

09:39 AM EST on 12/02/21

DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 1 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Current Price $0.94 Mkt Cap $213.9M
Open $0.95 P/E Ratio 0.00
Prev. Close $0.94 Div. (Yield) $0.00 (0.0%)
Daily Range $0.92 - $0.95 Volume 24,833
52-Wk Range $0.91 - $2.95 Avg. Daily Vol. 668,198

Caps

How do you think NASDAQ:DRRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

80 Outperform
20 Underperform
 

All-Star Players

11 Outperform
9 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:DRRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

hackwojr (97.58)
Submitted August 19, 2006

Durect has several products in phase II trials that will really be excellent for the treament of post operative pain. Striker, a company that would compete with Durect just purchased something like 18,000,000$ worth of shares of durect. They must… More

LifeScientist (28.83)
Submitted June 25, 2020

Pumping it, will be dumped. Rediculous thesis from pumpers about its candidate drug as support for Covid Remdesivir. Low short interest so narrow upside.

NASDAQ:DRRX VS S&P 500 (SPY)

Fools bullish on NASDAQ:DRRX are also bullish on:

Fools bearish on NASDAQ:DRRX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about DRRX.

Recs

1
Member Avatar LifeScientist (28.83) Submitted: 6/25/2020 3:30:55 PM : Underperform Start Price: $2.62 NASDAQ:DRRX Score: +110.87

Pumping it, will be dumped. Rediculous thesis from pumpers about its candidate drug as support for Covid Remdesivir. Low short interest so narrow upside.

Recs

0
Member Avatar marsuculix (20.02) Submitted: 9/22/2016 9:36:11 AM : Outperform Start Price: $1.73 NASDAQ:DRRX Score: -152.99

FDA approval highly possible

Recs

0
Member Avatar xmpyre (< 20) Submitted: 5/1/2014 4:30:47 AM : Outperform Start Price: $1.31 NASDAQ:DRRX Score: -167.67

Held by the whim of regulation...future regulatory decisions will make or break this company

Leaderboard

Find the members with the highest scoring picks in DRRX.

Score Leader

anticitradeshort

anticitradeshort (27.60) Score: +495.02

The Score Leader is the player with the highest score across all their picks in DRRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
anticitradeshort 27.60 4/20/2009 Underperform NS $2.52 -62.69% +432.33% +495.02 0 Comment
Maribaza 97.66 11/22/2010 Underperform 5Y $2.82 -66.66% +278.99% +345.66 2 Comments
luckybunni 79.84 5/8/2008 Underperform NS $4.63 -79.70% +233.94% +313.64 0 Comment
woodsst 75.27 1/25/2007 Underperform 5Y $4.53 -79.25% +232.54% +311.79 0 Comment
Jlesher 51.86 4/29/2011 Underperform 1Y $3.71 -74.66% +230.86% +305.52 0 Comment
richmouse 86.49 9/26/2007 Underperform 3M $5.44 -82.72% +210.77% +293.49 0 Comment
sscgiv 98.17 7/18/2007 Underperform 5Y $4.51 -79.16% +208.67% +287.83 0 Comment
hibetals 96.73 6/5/2007 Underperform NS $3.97 -76.32% +209.91% +286.23 0 Comment
IdahoInvestor 27.30 1/12/2012 Underperform 5Y $0.78 +20.23% +249.16% +228.93 0 Comment
mountaincouger 27.99 5/17/2013 Underperform 5Y $0.90 +4.41% +171.56% +167.15 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for DRRX.